Ophel (Opipramol Hydrochloride)

Opipramol Hydrochloride works by activating sigma‑1 receptors while blocking histamine H1, muscarinic, and serotonergic receptors. This unique receptor profile modulates neuronal activity, providing anxiolytic and antidepressant effects through enhanced neuroprotective signaling and reduced central nervous system excitability.

The dosage of Ophel is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Physicians determine the appropriate strength and frequency, and patients should follow the specific instructions provided on their prescription label.

Safety data for Opipramol Hydrochloride in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, so it should only be used when the potential benefit justifies any possible risk to the fetus or infant. Consultation with a healthcare professional is essential.

To order Ophel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any necessary import documentation.

Unlike benzodiazepines, Ophel does not act primarily on GABA receptors and therefore has a lower risk of dependence. Compared with selective serotonin reuptake inhibitors, Ophel’s mechanism involves sigma‑1 receptor agonism and broader receptor antagonism, offering a distinct therapeutic profile that may be preferable in certain anxiety or somatoform presentations.

Ophel tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect from moisture and direct sunlight, and ensure they are out of reach of children. Do not store in a refrigerator or freezer.

Ophel is taken orally as a tablet. Swallow the tablet whole with a glass of water, preferably with or after a meal to reduce gastrointestinal discomfort. Do not crush, chew, or split the tablet unless specifically instructed by a healthcare provider.

Serious adverse reactions, although rare, include cardiac arrhythmias or QT‑interval prolongation, severe hypotension, hepatic dysfunction, blood dyscrasias such as agranulocytosis, seizures, and emergence of suicidal thoughts or behaviors. Patients should seek immediate medical attention if any of these symptoms occur.

Ophel should be avoided in individuals with known hypersensitivity to Opipramol Hydrochloride or any tablet excipients, patients currently receiving monoamine oxidase inhibitors, those with severe hepatic impairment, and patients with a history of serious cardiac conduction disorders. A thorough medical review by a prescriber is required before initiating therapy.